Severe hepatitis in a HIV-positive subject under treatment with protease inhibitor.
Nigro
L
L
Romano
F
F
Tosto
S
S
Zagami
A
A
Bruno
S
S
Nunnari
A
A
D000328:Adult; D004279:DNA, Viral / Q000032:analysis; D005500:Follow-Up Studies; D006678:HIV / Q000276:immunology; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D006679:HIV Seropositivity / Q000188:drug therapy*; D006509:Hepatitis B / Q000175:diagnosis / Q000821:virology*; D006510:Hepatitis B Antibodies / Q000032:analysis; D006515:Hepatitis B virus / Q000235:genetics / Q000276:immunology; D006801:Humans; D019469:Indinavir / Q000627:therapeutic use*; D008297:Male
D004279:DNA, Viral; D017320:HIV Protease Inhibitors; D006510:Hepatitis B Antibodies; D019469:Indinavir